The thrombospondin-1/CD47 axis in kidney transplantation.

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Kidney transplantation is the preferred treatment for kidney failure. At transplantation when blood flow is restored to the organ, a massive burst of inflammatory and oxidative products ensues, a process known as “ischaemia-reperfusion injury” (IRI). This damages transplanted organs and activates the immune system, causing organ transplant rejection and loss. This project will investigate the TSP-1/CD47 axis and its manipulation in renal IRI as a focus for reducing organ injury, rejection and transplant failure.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2018

Funding Scheme: Early Career Fellowships

Funding Amount: $372,528.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Transplantation Immunology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

immune modulation | ischaemia/reperfusion | kidney disease | kidney transplantation | nitric oxide | reactive oxygen species (ROS) | rejection | transplantation | vascular biology